Ronald Li, BiotechnologyBioCardia's CardiAMP-HF Trial Shows Two-Year Survival, Reduced Cardiac Events100% left coverage1 source
Ronald Li, BiotechnologyBioCardia's CardiAMP-HF Trial Shows Two-Year Survival, Reduced Cardiac Events100% left coverage1 source